Caxton Associates (New York)’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$655K Buy
+2,902
New +$648K 0.02% 283
2023
Q3
Sell
-3,678
Closed -$692K 542
2023
Q2
$692K Sell
3,678
-463
-11% -$87.5K 0.1% 209
2023
Q1
$807K Sell
4,141
-62
-1% -$11.5K 0.12% 183
2022
Q4
$771K Buy
+4,203
New +$659K 0.05% 162
2021
Q4
Sell
-3,234
Closed -$601K 635
2021
Q3
$601K Sell
3,234
-808
-20% -$138K 0.07% 173
2021
Q2
$698K Sell
4,042
-4,902
-55% -$886K 0.08% 118
2021
Q1
$1.6M Buy
8,944
+7,568
+550% +$1.4M 0.15% 46
2020
Q4
$253K Buy
+1,376
New +$226K 0.02% 97
2013
Q3
Sell
-105,150
Closed -$4.44M 211
2013
Q2
$4.44M Buy
+105,150
New +$4.4M 0.22% 93

Other funds holding MSGS

Caxton Associates (New York)'s MSGS Position: Q4 2024 in Review

Caxton Associates (New York) opened a new position in Madison Square Garden (MSGS) in Q4 2024: 2,902 shares worth $655K. The stake represents 0.02% of the portfolio and ranks #283 among its holdings. This is a return to the name: Caxton Associates (New York) previously reported a position in MSGS as recently as Q2 2023.

Caxton Associates (New York) first reported a position in MSGS in Q2 2013 and has held it in 9 quarters since. The position peaked at $4.44M in Q2 2013. 343 funds tracked by Wall St. Rank hold MSGS as of Q4 2024.

  • Caxton Associates (New York) held 2,902 shares of Madison Square Garden worth $655K as of Q4 2024.
  • Madison Square Garden was a new Caxton Associates (New York) position in Q4 2024.
  • Madison Square Garden made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #283 holding.
  • Caxton Associates (New York) first reported a position in Madison Square Garden in Q2 2013 and has held it in 9 quarters since.
  • Caxton Associates (New York)'s Madison Square Garden position peaked at $4.44M in Q2 2013.
  • 343 funds tracked by Wall St. Rank held Madison Square Garden as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.